Next Science | NXS - Current Liabilities


Next Science reported $4.84M in Current Liabilities for its fiscal semester ending in June of 2025.



Current Liabilities Change Date
Alcidion AUD 22.33M 1.47M Dec/2025
Ansell USD 468.9M 53.1M Dec/2025
Fisher & Paykel Healthcare NZD 471.3M 29.1M Dec/2025
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Nanosonics AUD 36.59M 3.2M Dec/2025
Polynovo AUD 22.81M 5.07M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025